With the revival of psychedelic medicine well underway, different academic groups and clinical research companies are investigating the features and effects of psychedelic experiences on mental health.
Category Press Release
Country Canada
Companies Featured
Small PharmaSmall Pharma works on the development of two drugs. Together with Imperial College London they are developing intravenous administration DMT. The other project is a variant on ketamine (SPL801B).